Tevogen Inc. (TVGN) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US88165K2006
Tevogen Inc. financials
| Fiscal year | 2025 |
|---|---|
| Operating income | -26.14 m USD |
| EBIT | -26.27 m USD |
| Net income | -26.28 m USD |
| Diluted EPS – continuing operations | -8.08 USD |
Full history since 2021, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Tevogen Inc.
Tevogen Inc., a clinical-stage specialty immunotherapy company, develops off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and other disorders. The company develops TVGN 489, which has completed Phase 1 clinical trial for the treatment of ambulatory high-risk adult COVID-19 patients; and in Phase 1 clinical trial to treat acute SARS-CoV-2 patients with B-cell cancer immune suppression, and other B cell immune suppressed acute SARS-CoV-2 patients with a B cell cancer indication, as well as Long COVID prevention and treatment. It is also developing TVGN 920, a preclinical trial drug for treating cervical cancer; TVGN 960, a preclinical trial drug for treating oropharyngeal cancer; TVGN 601, a preclinical trial drug for treating multiple sclerosis; TVGN 930, a preclinical trial drug for treating Epstein-Barr virus associated lymphomas; and TVGN 116, a product candidate targeted at hepatitis B. It also offers artificial intelligence platform for drug development. Tevogen Inc. was formerly known as Tevogen Bio Holdings Inc. and changed its name to Tevogen Inc. in July 2026. The company was incorporated in 2020 and is headquartered in Warren, New Jersey.
More stocks
- Korea Petroleum Industries Co (004090.KS)
- Easywell Biomedicals Inc. (1799.TWO)
- United Purification Technology Co., Ltd. (6977.TWO)
- Wam Active Ltd (WAA.AX)
- LiveWire Group, Inc. (LVWR)
- Taiwan IC Packaging (3372.TWO)
- Formosa Pharmaceuticals, Inc. (6838.TW)
- Patagonia Gold Corp (PGDC.V)
- Tung Thih Electronic Co Ltd (3552.TWO)
- Cubtek Inc. (2252.TWO)
- Atlantic Sapphire As (ASA.OL)
- Taiwan Environment Scientific Co., Ltd. (8476.TW)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.